The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.

Annotation

coordinate NIM with specific drug /pharmacokin

DUI

D001682 MeSH Browser

CUI

M0002522

Previous indexing

Biopharmaceutics (1966-1974); Drug Compounding (1966-1969); Drugs (1966-1969); Pharmacology (1966-1969)

History note

79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; PHYSIOLOGIC AVAILABILITY was see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOPHARMACEUTICS 1970-79 and see under BIOLOGICAL AVAILABILITY 1980-86

Online note

use BIOLOGICAL AVAILABILITY to search AVAILABILITY EQUIVALENCY 1980-86, BIOLOGIC AVAILABILITY & PHYSIOLOGIC AVAILABILITY 1975-79, & BIOPHARMACEUTICS 1970-74

Public note

79; was BIOLOGIC AVAILABILITY see under BIOPHARMACEUTICS 1970-78; AVAILABILITY EQUIVALENCY & PHYSIOLOGIC AVAILABILITY were see under BIOPHARMACEUTICS 1970-79; AVAILABILITY EQUIVALENCY was see under BIOLOGICAL AVAILABILITY 1980-86